Trials / Not Yet Recruiting
Not Yet RecruitingNCT06561009
Safety and Efficacy of BAFFR CART for Relapsed/ Refractory Neuromyelitis Optica Spectrum Disorder
- Status
- Not Yet Recruiting
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Tianjin Medical University General Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
This is an open-label, single-arm, dose-escalation study in up to 20 participants with relapsed/refractory Neuromyelitis Optica Spectrum Disorders (NMOSD). The aim is to evaluate the safety and efficacy of the treatment with BAFFR CART.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Anti-BAFFR CART | Anti-BAFFR CART |
Timeline
- Start date
- 2025-12-01
- Primary completion
- 2027-10-01
- Completion
- 2028-10-01
- First posted
- 2024-08-19
- Last updated
- 2025-05-30
Source: ClinicalTrials.gov record NCT06561009. Inclusion in this directory is not an endorsement.